Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-β-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis
Gespeichert in:
| Veröffentlicht in: | Journal of antimicrobial chemotherapy 2011-11, Vol.66 (11), p.2677-2678 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2678 |
|---|---|
| container_issue | 11 |
| container_start_page | 2677 |
| container_title | Journal of antimicrobial chemotherapy |
| container_volume | 66 |
| creator | Stone, Neil R. H. Woodford, Neil Livermore, David M. Howard, Julia Pike, Rachel Mushtaq, Shazad Perry, Claire Hopkins, Susan |
| description | |
| doi_str_mv | 10.1093/jac/dkr337 |
| format | Article |
| fullrecord | <record><control><sourceid>oup_pubme</sourceid><recordid>TN_cdi_pubmed_primary_21846669</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/jac/dkr337</oup_id><sourcerecordid>10.1093/jac/dkr337</sourcerecordid><originalsourceid>FETCH-LOGICAL-o238t-ee2a56e4539367b97f5158334b49ac0b6db90d20a6d7817ad2120629495e47723</originalsourceid><addsrcrecordid>eNpFkc1u1TAQhS0EopfChgdA3iDBwtR_seMltOVHKmUD62jizG3cOjeR7ajc10LiNXgmXN1CpZFmMZ_OGZ1DyEvB3wnu1Mk1-JPhJillH5GN0IYzyZ14TDZc8YZZ3agj8izna865aUz7lBxJ0WpjjNuQ3x8Swk0Z07xejbQHXzABTgHosCItMy3hCv3ex7BDljCHXGBX6Hn2I6bgxwr6OQZ6G8pIL_GWnmEcA52wQIwz-_OLxaoJE2Skby7Pvr5lgubVe8x5u8a4p6X6FxwOAndSuYQdrQN0gRKwmh1OEH1Yxn2EnyE_J0-2EDO-uN_H5MfH8--nn9nFt09fTt9fsFmqtjBECY3BGoBTxvbObhvRtErpXjvwvDdD7_ggOZjBtsLCIIXkRjrtGtTWSnVMXh10l7WfcOiWFCZI--5ffhV4fQ9Arh9uE-x8yA-cNrK1Tj9w87r8vwre3fXX1f66Q3_qLwNqj0o</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-β-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Stone, Neil R. H. ; Woodford, Neil ; Livermore, David M. ; Howard, Julia ; Pike, Rachel ; Mushtaq, Shazad ; Perry, Claire ; Hopkins, Susan</creator><creatorcontrib>Stone, Neil R. H. ; Woodford, Neil ; Livermore, David M. ; Howard, Julia ; Pike, Rachel ; Mushtaq, Shazad ; Perry, Claire ; Hopkins, Susan</creatorcontrib><identifier>ISSN: 0305-7453</identifier><identifier>EISSN: 1460-2091</identifier><identifier>DOI: 10.1093/jac/dkr337</identifier><identifier>PMID: 21846669</identifier><identifier>CODEN: JACHDX</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents ; Bacteremia - complications ; Bacteremia - drug therapy ; Bacterial diseases ; Bacterial sepsis ; beta-Lactamases - metabolism ; Biological and medical sciences ; Calciphylaxis - complications ; Calciphylaxis - microbiology ; Coinfection ; Colistin - administration & dosage ; Colistin - pharmacology ; Colistin - therapeutic use ; Drug Resistance, Bacterial ; Escherichia coli - drug effects ; Escherichia coli - enzymology ; Escherichia coli Infections - complications ; Escherichia coli Infections - drug therapy ; Escherichia coli Infections - microbiology ; Human bacterial diseases ; Humans ; Infectious diseases ; Klebsiella Infections - complications ; Klebsiella Infections - drug therapy ; Klebsiella Infections - microbiology ; Klebsiella pneumoniae - drug effects ; Medical sciences ; Middle Aged ; Minocycline - analogs & derivatives ; Minocycline - pharmacology ; Minocycline - therapeutic use ; Pharmacology. Drug treatments</subject><ispartof>Journal of antimicrobial chemotherapy, 2011-11, Vol.66 (11), p.2677-2678</ispartof><rights>The Author 2011. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com 2011</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1578,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24628794$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21846669$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stone, Neil R. H.</creatorcontrib><creatorcontrib>Woodford, Neil</creatorcontrib><creatorcontrib>Livermore, David M.</creatorcontrib><creatorcontrib>Howard, Julia</creatorcontrib><creatorcontrib>Pike, Rachel</creatorcontrib><creatorcontrib>Mushtaq, Shazad</creatorcontrib><creatorcontrib>Perry, Claire</creatorcontrib><creatorcontrib>Hopkins, Susan</creatorcontrib><title>Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-β-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis</title><title>Journal of antimicrobial chemotherapy</title><addtitle>J Antimicrob Chemother</addtitle><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Bacteremia - complications</subject><subject>Bacteremia - drug therapy</subject><subject>Bacterial diseases</subject><subject>Bacterial sepsis</subject><subject>beta-Lactamases - metabolism</subject><subject>Biological and medical sciences</subject><subject>Calciphylaxis - complications</subject><subject>Calciphylaxis - microbiology</subject><subject>Coinfection</subject><subject>Colistin - administration & dosage</subject><subject>Colistin - pharmacology</subject><subject>Colistin - therapeutic use</subject><subject>Drug Resistance, Bacterial</subject><subject>Escherichia coli - drug effects</subject><subject>Escherichia coli - enzymology</subject><subject>Escherichia coli Infections - complications</subject><subject>Escherichia coli Infections - drug therapy</subject><subject>Escherichia coli Infections - microbiology</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Klebsiella Infections - complications</subject><subject>Klebsiella Infections - drug therapy</subject><subject>Klebsiella Infections - microbiology</subject><subject>Klebsiella pneumoniae - drug effects</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Minocycline - analogs & derivatives</subject><subject>Minocycline - pharmacology</subject><subject>Minocycline - therapeutic use</subject><subject>Pharmacology. Drug treatments</subject><issn>0305-7453</issn><issn>1460-2091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkc1u1TAQhS0EopfChgdA3iDBwtR_seMltOVHKmUD62jizG3cOjeR7ajc10LiNXgmXN1CpZFmMZ_OGZ1DyEvB3wnu1Mk1-JPhJillH5GN0IYzyZ14TDZc8YZZ3agj8izna865aUz7lBxJ0WpjjNuQ3x8Swk0Z07xejbQHXzABTgHosCItMy3hCv3ex7BDljCHXGBX6Hn2I6bgxwr6OQZ6G8pIL_GWnmEcA52wQIwz-_OLxaoJE2Skby7Pvr5lgubVe8x5u8a4p6X6FxwOAndSuYQdrQN0gRKwmh1OEH1Yxn2EnyE_J0-2EDO-uN_H5MfH8--nn9nFt09fTt9fsFmqtjBECY3BGoBTxvbObhvRtErpXjvwvDdD7_ggOZjBtsLCIIXkRjrtGtTWSnVMXh10l7WfcOiWFCZI--5ffhV4fQ9Arh9uE-x8yA-cNrK1Tj9w87r8vwre3fXX1f66Q3_qLwNqj0o</recordid><startdate>20111101</startdate><enddate>20111101</enddate><creator>Stone, Neil R. H.</creator><creator>Woodford, Neil</creator><creator>Livermore, David M.</creator><creator>Howard, Julia</creator><creator>Pike, Rachel</creator><creator>Mushtaq, Shazad</creator><creator>Perry, Claire</creator><creator>Hopkins, Susan</creator><general>Oxford University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20111101</creationdate><title>Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-β-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis</title><author>Stone, Neil R. H. ; Woodford, Neil ; Livermore, David M. ; Howard, Julia ; Pike, Rachel ; Mushtaq, Shazad ; Perry, Claire ; Hopkins, Susan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-o238t-ee2a56e4539367b97f5158334b49ac0b6db90d20a6d7817ad2120629495e47723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Bacteremia - complications</topic><topic>Bacteremia - drug therapy</topic><topic>Bacterial diseases</topic><topic>Bacterial sepsis</topic><topic>beta-Lactamases - metabolism</topic><topic>Biological and medical sciences</topic><topic>Calciphylaxis - complications</topic><topic>Calciphylaxis - microbiology</topic><topic>Coinfection</topic><topic>Colistin - administration & dosage</topic><topic>Colistin - pharmacology</topic><topic>Colistin - therapeutic use</topic><topic>Drug Resistance, Bacterial</topic><topic>Escherichia coli - drug effects</topic><topic>Escherichia coli - enzymology</topic><topic>Escherichia coli Infections - complications</topic><topic>Escherichia coli Infections - drug therapy</topic><topic>Escherichia coli Infections - microbiology</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Klebsiella Infections - complications</topic><topic>Klebsiella Infections - drug therapy</topic><topic>Klebsiella Infections - microbiology</topic><topic>Klebsiella pneumoniae - drug effects</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Minocycline - analogs & derivatives</topic><topic>Minocycline - pharmacology</topic><topic>Minocycline - therapeutic use</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stone, Neil R. H.</creatorcontrib><creatorcontrib>Woodford, Neil</creatorcontrib><creatorcontrib>Livermore, David M.</creatorcontrib><creatorcontrib>Howard, Julia</creatorcontrib><creatorcontrib>Pike, Rachel</creatorcontrib><creatorcontrib>Mushtaq, Shazad</creatorcontrib><creatorcontrib>Perry, Claire</creatorcontrib><creatorcontrib>Hopkins, Susan</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Journal of antimicrobial chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stone, Neil R. H.</au><au>Woodford, Neil</au><au>Livermore, David M.</au><au>Howard, Julia</au><au>Pike, Rachel</au><au>Mushtaq, Shazad</au><au>Perry, Claire</au><au>Hopkins, Susan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-β-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis</atitle><jtitle>Journal of antimicrobial chemotherapy</jtitle><addtitle>J Antimicrob Chemother</addtitle><date>2011-11-01</date><risdate>2011</risdate><volume>66</volume><issue>11</issue><spage>2677</spage><epage>2678</epage><pages>2677-2678</pages><issn>0305-7453</issn><eissn>1460-2091</eissn><coden>JACHDX</coden><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>21846669</pmid><doi>10.1093/jac/dkr337</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0305-7453 |
| ispartof | Journal of antimicrobial chemotherapy, 2011-11, Vol.66 (11), p.2677-2678 |
| issn | 0305-7453 1460-2091 |
| language | eng |
| recordid | cdi_pubmed_primary_21846669 |
| source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry |
| subjects | Antibiotics. Antiinfectious agents. Antiparasitic agents Bacteremia - complications Bacteremia - drug therapy Bacterial diseases Bacterial sepsis beta-Lactamases - metabolism Biological and medical sciences Calciphylaxis - complications Calciphylaxis - microbiology Coinfection Colistin - administration & dosage Colistin - pharmacology Colistin - therapeutic use Drug Resistance, Bacterial Escherichia coli - drug effects Escherichia coli - enzymology Escherichia coli Infections - complications Escherichia coli Infections - drug therapy Escherichia coli Infections - microbiology Human bacterial diseases Humans Infectious diseases Klebsiella Infections - complications Klebsiella Infections - drug therapy Klebsiella Infections - microbiology Klebsiella pneumoniae - drug effects Medical sciences Middle Aged Minocycline - analogs & derivatives Minocycline - pharmacology Minocycline - therapeutic use Pharmacology. Drug treatments |
| title | Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-β-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T05%3A57%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Breakthrough%20bacteraemia%20due%20to%20tigecycline-resistant%20Escherichia%20coli%20with%20New%20Delhi%20metallo-%CE%B2-lactamase%20(NDM)-1%20successfully%20treated%20with%20colistin%20in%20a%20patient%20with%20calciphylaxis&rft.jtitle=Journal%20of%20antimicrobial%20chemotherapy&rft.au=Stone,%20Neil%20R.%20H.&rft.date=2011-11-01&rft.volume=66&rft.issue=11&rft.spage=2677&rft.epage=2678&rft.pages=2677-2678&rft.issn=0305-7453&rft.eissn=1460-2091&rft.coden=JACHDX&rft_id=info:doi/10.1093/jac/dkr337&rft_dat=%3Coup_pubme%3E10.1093/jac/dkr337%3C/oup_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/21846669&rft_oup_id=10.1093/jac/dkr337&rfr_iscdi=true |